IRIDEX stock: Q3 results set for November 17

Published on 11/05/2026 at 02:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IRIDEX stock has a scheduled earnings catalyst on November 17. Management will pair the release with a business update and investor call.

Upcoming results set investor focus

IRIDEX plans to release third-quarter 2026 results after the market closes on November 17.
Management will provide a business update during a conference call scheduled for 5:00 p.m. Eastern Time.
The company sells laser systems and consumable probes for ophthalmic treatments in the United States and more than 100 other countries.

IRIX, US4626841013, Illustration mit AI erstellt.

IRIDEX announced on November 3 that it will release financial results for the third quarter of 2026 after the close of trading on November 17. The announcement, carried by BioSpace, makes the reporting date the next scheduled event for investors in the ophthalmic-device maker.

Results date and investor call

The release is planned for after the U.S. market closes on Tuesday, November 17. Management will host a conference call at 2:00 p.m. Pacific Time, or 5:00 p.m. Eastern Time, to discuss the results and provide a business update.

Investors can join by calling 1-800-715-9871 in the United States or 1-646-307-1963 internationally, using conference ID 7118799. IRIDEX also plans to provide a live and recorded webcast through the Event Calendar in the Investors section of its website.

What the company makes

IRIDEX develops, manufactures and markets laser-based medical systems, capital equipment and consumable probes for ophthalmology. Its MicroPulse technology is designed to deliver laser treatment while limiting tissue damage, and its products address glaucoma, diabetic macular edema and other retinal diseases. The company sells directly in the United States and through independent distributors in more than 100 countries.